Chemed Corporation (NYSE: CHE) reported Q1 EPS of $5.20, $0.27 worse than the analyst estimate of $5.47. Revenue for the quarter came in at $589.2 million versus the consensus estimate of $591.12 million.

GUIDANCE:

Chemed Corporation sees FY2024 EPS of $23.30-$23.70, versus the consensus of $23.52.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.